Clinical Trials
16
Active:2
Completed:4
Trial Phases
3 Phases
Phase 1:2
Phase 4:4
Not Applicable:7
Drug Approvals
137
FDA:137
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Not Applicable
7 (53.8%)Phase 4
4 (30.8%)Phase 1
2 (15.4%)No trials found
News
Alembic Pharma Gains USFDA Approval for Diltiazem Hydrochloride ER Capsules
Alembic Pharmaceuticals has received USFDA final approval for its Diltiazem Hydrochloride Extended-Release Capsules USP, in multiple strengths.